NCT04521686 2026-04-22
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Phase 1 Active not recruiting
Clinical Trials
14 trialsNCT06749366 2026-04-20
Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing
National Institutes of Health Clinical Center (CC)
Recruiting
NCT03442465 2026-04-17
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
Memorial Sloan Kettering Cancer Center
Recruiting
NCT05039801 2026-04-15
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT01267955 2026-04-13
Vismodegib in Treating Patients With Advanced Chondrosarcomas
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT06176989 2026-04-08
Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT07492823 2026-03-25
Clinical Applicability of Liquid Biopsy in Chondrosarcoma
Medical University of Graz
Not yet recruiting
NCT05033288 2026-03-13
Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
Mayo Clinic
Recruiting
NCT00496522 2026-03-09
Proton Beam Therapy for Chondrosarcoma
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04091295 2026-03-04
BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast
Aveni Foundation
Available
NCT02073994 2026-02-17
Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Servier
Phase 1 Completed
NCT04055220 2026-02-17
REGOSTA
Centre Leon Berard
Phase NA Recruiting
NCT06387485 2026-02-06
A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
Ricoh USA, Inc.
Phase NA Recruiting
NCT05779670 2026-02-03
ADER
Istituto Ortopedico Rizzoli
Recruiting